Parker Research Institute赞助的临床试验
总计18935个结果
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)招聘中
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)主动,不招人
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)终止
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)Dana-Farber Cancer Institute撤销
-
Dana-Farber Cancer InstituteImmunityBio, Inc.尚未招聘
-
Dana-Farber Cancer InstituteCelldex Therapeutics招聘中
-
Dana-Farber Cancer InstituteGenentech, Inc.招聘中乳腺癌 | HER2阳性乳腺癌 | 激素受体阳性乳腺癌 | 浸润性乳腺癌 | 淋巴结阴性乳腺癌 | 微转移乳腺癌美国
-
Dana-Farber Cancer InstituteGenentech, Inc.主动,不招人
-
Dana-Farber Cancer InstituteIncyte Corporation主动,不招人
-
Dana-Farber Cancer InstituteHiberCell, Inc.完全的
-
Dana-Farber Cancer InstituteEisai Inc.主动,不招人
-
Dana-Farber Cancer InstituteAmbry Genetics完全的
-
Dana-Farber Cancer InstituteGenentech, Inc.主动,不招人
-
Dana-Farber Cancer InstituteEntrinsic Health完全的
-
Dana-Farber Cancer InstituteJanssen, LP完全的
-
Dana-Farber Cancer InstituteGenentech, Inc.终止
-
Dana-Farber Cancer InstituteBayer; Pfizer完全的
-
Dana-Farber Cancer InstituteIncyte Corporation完全的
-
Dana-Farber Cancer InstituteNovartis; AstraZeneca完全的
-
AEterna ZentarisDana-Farber Cancer Institute完全的
-
Fate TherapeuticsDana-Farber Cancer Institute完全的
-
Dana-Farber Cancer InstituteRegeneron Pharmaceuticals主动,不招人
-
Dana-Farber Cancer InstituteBayer; AbbVie主动,不招人
-
Dana-Farber Cancer InstitutePrometheus Laboratories主动,不招人
-
Dana-Farber Cancer InstituteGilead Sciences主动,不招人
-
Dana-Farber Cancer InstituteMedivation, Inc.完全的